Summary: Scientists have traced the earliest cellular origins of Rett syndrome by separating genetically normal and mutant brain cells from the same mosaic female hippocampus before profiling them. This approach revealed an early molecular signature and a highly vulnerable neuron type that break down well before symptoms appear.
Using a combination of bulk and single-nucleus RNA sequencing in the hippocampus, the team identified a consistent 12-gene presymptomatic signature linked to synaptic failure and singled out a specialized cell type, the trilaminar interneuron, as especially susceptible to early genetic dysfunction.
Key Facts
- The Mosaic Conundrum: Rett syndrome is a rare neurodevelopmental disorder caused by mutations in the X-linked gene MECP2. Because females undergo random X-chromosome inactivation, their brains are mosaic: many neurons express functional MeCP2 while others express the mutant form, creating a mixed cellular environment.
- Bypassing Tissue Overlap: Traditional bulk RNA sequencing of whole tissue blurs changes in mutant cells because healthy cells dilute their signal. To overcome this, researchers physically separated MeCP2-positive and MeCP2-negative cells from the same mosaic female hippocampus and profiled them individually.
- The 12-Gene Presymptomatic Blueprint: Comparing cellular profiles across sexes and genotypes, the investigators found a core set of 12 genes consistently dysregulated in mutant cells at presymptomatic stages. These genes are involved in synapse formation and function, indicating that impaired neuronal communication is an early event in disease progression.
- Discovery of the Trilaminar Interneuron Defect: Single-nucleus data revealed that trilaminar interneurons—a specialized inhibitory neuron type that spans multiple hippocampal layers—showed the most severe transcriptional disruption. These cells are poised to coordinate complex hippocampal signaling and appear uniquely vulnerable to MeCP2 loss.
- The Toxic Cellular Neighborhood Effect: The study also shows that genetically normal (MeCP2-positive) cells in females are affected by nearby mutant cells. The altered microenvironment produced by mutant neighbors perturbs gene expression in otherwise healthy neurons, helping explain widespread brain dysfunction in Rett syndrome.
- Translational Implications for Early Intervention: Identifying a compact, early molecular signature and the most vulnerable cell types creates objective biomarkers for testing therapies. Targeting the 12 core genes or protecting trilaminar interneurons could open a window to slow or prevent symptom onset if applied before clinical decline.
Source: Baylor College of Medicine
Researchers at Baylor College of Medicine and the Duncan Neurological Research Institute at Texas Children’s Hospital examined hippocampal cells from mouse models of Rett syndrome before symptoms appeared to discover which genes and cell types are affected earliest by MECP2 dysfunction.
The study is published in Science Advances.
Rett syndrome primarily affects girls. Although development may appear normal in early infancy, most affected children begin to lose acquired skills—such as speech, purposeful hand movements and social engagement—between about 6 and 18 months of age.
“Rett syndrome arises from mutations in MECP2, a gene that helps regulate the activity of thousands of other genes in the brain,” said corresponding author Dr. Huda Zoghbi, Distinguished Service Professor at Baylor and director of the Duncan NRI. Loss of MeCP2 function disrupts gene regulation on a broad scale.
Co-first author Dr. Ashley Anderson explained that because MECP2 sits on the X chromosome, females have two Xs and randomly inactivate one per cell. This creates a mosaic brain in which roughly half of neurons express the healthy MeCP2 protein and the other half express the mutant form. Male patients, with only a single X chromosome, typically express the mutant form in all cells and often show more severe early disease.
Co-first author Yan Li added that healthy and mutant cells influence one another, complicating studies of Rett. By analyzing female mice that model mosaicism alongside male mice with uniform MeCP2 loss, the team began to untangle cell-autonomous effects from those imposed by the surrounding cellular environment.
The investigators focused on the hippocampus, a brain region critical for learning and memory and known to be affected early in Rett syndrome. A key technical advance in this work was physically separating MeCP2-positive and MeCP2-negative cells before molecular profiling, enabling direct comparison of gene activity in mutant and healthy cells from the same brain for the first time.
They combined bulk RNA sequencing, which captures overall tissue-level changes, with single-nucleus RNA sequencing, which resolves gene activity within individual cell types. Bulk methods showed only modest changes in female hippocampal tissue, but single-nucleus analysis revealed pronounced, cell-type specific disruptions hidden in averaged measurements.
“We found 12 genes that were consistently altered at early stages and only within MeCP2-deficient cells,” Anderson said. “These genes were either up- or down-regulated in the same pattern regardless of sex or disease severity. Many are involved in synaptic communication, indicating that defects in neuronal connectivity are an initial step in Rett pathogenesis.”
The study also found that some MeCP2-normal cells in females show altered gene expression because of neighboring mutant cells. This non–cell autonomous effect means that cell interactions within the mosaic brain contribute to broad dysfunction even when many neurons carry the healthy gene.
Trilaminar interneurons emerged as an unexpected and highly vulnerable cell type. These inhibitory neurons bridge multiple hippocampal layers and help coordinate circuit-level signaling; when MeCP2 function is lost they display stronger transcriptional disruption than other neuron types. Further research will be needed to clarify how their dysfunction contributes to disease symptoms.
“Identifying early, cell-specific molecular changes gives us markers to track whether interventions are working and points to cellular targets for protection,” Zoghbi said. “If therapies can correct these early disruptions or shield the most vulnerable cells, it may be possible to delay or prevent clinical progression. These findings also inform studies of other disorders involving mosaicism or selective cell vulnerabilities.”
Additional contributors include Guantong Qi, Sih-Rong Wu, Jean-Pierre Revelli, Hu Chen and Zhandong Liu from Baylor College of Medicine and the Duncan NRI.
Funding: This research was supported by the National Institute of Neurological Disorders and Stroke (R01NS057819, F32N122920-01A1), the Howard Hughes Medical Institute, the RNA In Situ Hybridization Core at Baylor College of Medicine, a Shared Instrumentation grant from the NIH (1S10OD016167), and the NIH IDDRC grant P50 HD103555 from the Eunice Kennedy Shriver National Institute of Child Health & Human Development.
Key Questions Answered:
A: The genetic disruptions caused by MECP2 mutations accumulate at the cellular level before symptoms appear. This study shows that a core set of 12 synapse-related genes becomes disrupted inside mutant neurons well before motor and language decline. Once enough synaptic connections fail, the brain can no longer compensate, and clinical symptoms emerge between roughly 6 and 18 months.
A: Mosaicism refers to the coexistence of genetically different cells within the same brain. In females with Rett syndrome, random X-inactivation produces a mix of MeCP2-normal and MeCP2-deficient cells. When researchers previously analyzed mixed tissue, signals from healthy cells masked early, cell-specific changes occurring in mutant cells.
A: Trilaminar interneurons are inhibitory cells that span several hippocampal layers to coordinate information flow. The study found these neurons show the most severe transcriptional disruption when MeCP2 is lost, making them a precise cellular target for interventions that aim to preserve circuit communication and delay disease progression.
Editorial Notes:
- This article was edited by a Neuroscience News editor.
- The original journal paper was reviewed in full.
- Additional contextual details were added by editorial staff.
About this autism and genetics research news
Author: Graciela Gutierrez
Source: Baylor College of Medicine
Contact: Graciela Gutierrez – Baylor College of Medicine
Image: The image is credited to Neuroscience News
Original Research: Open access. “Single-nucleus profiling reveals a core disease signature and cell type–specific vulnerabilities in early Rett syndrome” by Yan Li, Ashley G. Anderson, Guantong Qi, Sih-Rong Wu, Jean-Pierre Revelli, Hu Chen, Zhandong Liu, and Huda Y. Zoghbi. DOI: 10.1126/sciadv.aeb4265
Abstract
Single-nucleus profiling reveals a core disease signature and cell type–specific vulnerabilities in early Rett syndrome
Rett syndrome (RTT) is an X-linked neurological disorder driven by MECP2 mutations, which generate distinct cellular conditions in females (mosaic) versus males (nonmosaic).
Although females account for most clinical cases, how mosaicism shapes RTT pathogenesis at presymptomatic stages is not well understood. To address this, the authors profiled hippocampal transcriptomes from young female and male RTT mice using both bulk and single-nucleus RNA sequencing.
They identified a core disease signature of genes consistently dysregulated only in MeCP2-deficient cells across RTT models. The data also revealed non–cell autonomous effects in female MeCP2-positive excitatory neurons and highlighted an interneuron subtype with the greatest transcriptional disturbance in both sexes. Overall, the findings emphasize distinct impacts of MeCP2 loss on excitatory and inhibitory circuits in mosaic versus nonmosaic environments during early RTT pathogenesis.